Mirion Technologies (NYSE:MIR) Given New $24.00 Price Target at Citigroup

Mirion Technologies (NYSE:MIR) had its price objective hoisted by Citigroup from $23.00 to $24.00 in a research report released on Monday morning,Benzinga reports. Citigroup currently has a buy rating on the stock.

Several other research firms have also recently commented on MIR. B. Riley lowered their target price on shares of Mirion Technologies from $19.00 to $17.00 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. Robert W. Baird raised their price objective on shares of Mirion Technologies from $20.00 to $22.00 and gave the company an “outperform” rating in a research report on Wednesday, July 9th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $21.00.

Mirion Technologies Stock Up 1.8%

MIR stock opened at $20.78 on Monday. The stock has a market cap of $4.82 billion, a PE ratio of -346.37 and a beta of 0.83. The company has a quick ratio of 1.69, a current ratio of 2.23 and a debt-to-equity ratio of 0.44. The firm’s 50-day simple moving average is $19.25 and its 200 day simple moving average is $16.75. Mirion Technologies has a fifty-two week low of $9.11 and a fifty-two week high of $22.21.

Mirion Technologies (NYSE:MIR) last released its earnings results on Tuesday, April 29th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. The firm had revenue of $202.00 million for the quarter, compared to analysts’ expectations of $199.34 million. Mirion Technologies had a negative net margin of 1.16% and a positive return on equity of 6.07%. Mirion Technologies’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the company earned $0.06 EPS. As a group, sell-side analysts predict that Mirion Technologies will post 0.39 EPS for the current year.

Insider Buying and Selling at Mirion Technologies

In other news, Director Lawrence D. Kingsley sold 500,000 shares of the firm’s stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $17.94, for a total transaction of $8,970,000.00. Following the completion of the transaction, the director owned 61,287 shares in the company, valued at approximately $1,099,488.78. This trade represents a 89.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 6.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. US Bancorp DE raised its position in Mirion Technologies by 3,248.7% during the fourth quarter. US Bancorp DE now owns 6,262 shares of the company’s stock valued at $109,000 after acquiring an additional 6,075 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Mirion Technologies by 2.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,599,211 shares of the company’s stock valued at $27,906,000 after purchasing an additional 39,635 shares during the period. Raymond James Financial Inc. bought a new position in shares of Mirion Technologies in the fourth quarter valued at approximately $17,164,000. Swiss National Bank raised its position in shares of Mirion Technologies by 0.5% in the fourth quarter. Swiss National Bank now owns 376,800 shares of the company’s stock valued at $6,575,000 after purchasing an additional 2,000 shares during the period. Finally, Corient Private Wealth LLC bought a new position in shares of Mirion Technologies in the fourth quarter valued at approximately $187,000. 78.51% of the stock is currently owned by institutional investors and hedge funds.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.